BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22156972)

  • 1. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
    Bambha K; Pierce C; Cox C; French AL; Tien PC; Sharp GB; Augenbraun M; Glesby MJ; Villacres MC; Plankey M; Strickler HD; Gange SJ; Peters MG
    AIDS; 2012 Mar; 26(5):599-607. PubMed ID: 22156972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
    Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
    AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
    Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
    Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
    Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
    BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
    PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
    Jain MK; Seremba E; Bhore R; Dao D; Joshi R; Attar N; Yuan HJ; Lee WM
    AIDS Patient Care STDS; 2012 Feb; 26(2):73-80. PubMed ID: 22239101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
    Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
    BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
    Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis-4 index predicts mortality in HIV/HCV co-infected patients receiving combination antiretroviral therapy in rural China.
    Chen X; Liu X; Tang R; Ye R; Yang Y; Yao S; Wang J; Ding Y; Duan S; He N
    Biosci Trends; 2019 Mar; 13(1):32-39. PubMed ID: 30726798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
    Kuniholm MH; Gao X; Xue X; Kovacs A; Marti D; Thio CL; Peters MG; Greenblatt RM; Goedert JJ; Cohen MH; Minkoff H; Gange SJ; Anastos K; Fazzari M; Young MA; Strickler HD; Carrington M
    J Infect Dis; 2011 Jun; 203(12):1807-14. PubMed ID: 21606539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.
    Nunes D; Fleming C; Offner G; Craven D; Fix O; Heeren T; Koziel MJ; Graham C; Tumilty S; Skolnik P; Stuver S; Horsburgh CR; Cotton D
    Am J Gastroenterol; 2010 Jun; 105(6):1346-53. PubMed ID: 20179698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
    Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
    BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
    Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
    BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
    Al-Mohri H; Murphy T; Lu Y; Lalonde RG; Klein MB
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):463-9. PubMed ID: 17211282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
    Valcour VG; Rubin LH; Obasi MU; Maki PM; Peters MG; Levin S; Crystal HA; Young MA; Mack WJ; Cohen MH; Pierce CB; Adimora AA; Tien PC;
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):266-73. PubMed ID: 26885801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.
    Moodie EE; Pant Pai N; Klein MB
    PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
    Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
    HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
    Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
    World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.